Evidence map›Paper›PMID 41830405›Full record

ArticlePlant biotechnology journal2026

A Near Telomere-to-Telomere Genome of Belamcanda chinensis Provides Insights Into Genome Evolution and the Biosynthesis of Characteristic Isoflavones.

Yuan-Yuan Wang, Bi-Huan Chen, Gui-Sheng Xiang, Yi-Na Wang, Run Yang, Xiao-Bo Li, Shi-Yan Yuan, Yu-Cheng Zhao, Guang-Hui Zhang, Min-Jian Qin and 1 more

Abstract read
In one paragraph

Article in Plant biotechnology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yuan-Yuan WangCollege of Agronomy and Biotechnology, National-Local Joint Engineering Research Center on Gemplasm Innovation & Utilization of Chinese Medicinal Materials in Southwest, the Key Laboratory of Medicinal Plant Biology of Yunnan Province, Yunnan Agricultural University, Kunming, Yunnan, China.
Bi-Huan ChenCollege of Agronomy and Biotechnology, National-Local Joint Engineering Research Center on Gemplasm Innovation & Utilization of Chinese Medicinal Materials in Southwest, the Key Laboratory of Medicinal Plant Biology of Yunnan Province, Yunnan Agricultural University, Kunming, Yunnan, China.
Gui-Sheng XiangCollege of Agronomy and Biotechnology, National-Local Joint Engineering Research Center on Gemplasm Innovation & Utilization of Chinese Medicinal Materials in Southwest, the Key Laboratory of Medicinal Plant Biology of Yunnan Province, Yunnan Agricultural University, Kunming, Yunnan, China.
Yi-Na WangCollege of Agronomy and Biotechnology, National-Local Joint Engineering Research Center on Gemplasm Innovation & Utilization of Chinese Medicinal Materials in Southwest, the Key Laboratory of Medicinal Plant Biology of Yunnan Province, Yunnan Agricultural University, Kunming, Yunnan, China.
Run YangCollege of Agronomy and Biotechnology, National-Local Joint Engineering Research Center on Gemplasm Innovation & Utilization of Chinese Medicinal Materials in Southwest, the Key Laboratory of Medicinal Plant Biology of Yunnan Province, Yunnan Agricultural University, Kunming, Yunnan, China.
Xiao-Bo LiCollege of Agronomy and Biotechnology, National-Local Joint Engineering Research Center on Gemplasm Innovation & Utilization of Chinese Medicinal Materials in Southwest, the Key Laboratory of Medicinal Plant Biology of Yunnan Province, Yunnan Agricultural University, Kunming, Yunnan, China.
Shi-Yan YuanCollege of Agronomy and Biotechnology, National-Local Joint Engineering Research Center on Gemplasm Innovation & Utilization of Chinese Medicinal Materials in Southwest, the Key Laboratory of Medicinal Plant Biology of Yunnan Province, Yunnan Agricultural University, Kunming, Yunnan, China.
Yu-Cheng ZhaoDepartment of Resources Science of Traditional Chinese Medicines, School of Traditional Chinese Pharmacy, and State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, China.
Guang-Hui ZhangCollege of Agronomy and Biotechnology, National-Local Joint Engineering Research Center on Gemplasm Innovation & Utilization of Chinese Medicinal Materials in Southwest, the Key Laboratory of Medicinal Plant Biology of Yunnan Province, Yunnan Agricultural University, Kunming, Yunnan, China.
Min-Jian QinDepartment of Resources Science of Traditional Chinese Medicines, School of Traditional Chinese Pharmacy, and State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, China.ORCID https://orcid.org/0000-0001-8539-7649
Sheng-Chao YangCollege of Agronomy and Biotechnology, National-Local Joint Engineering Research Center on Gemplasm Innovation & Utilization of Chinese Medicinal Materials in Southwest, the Key Laboratory of Medicinal Plant Biology of Yunnan Province, Yunnan Agricultural University, Kunming, Yunnan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Belamcanda chinensis is a non-leguminous medicinal plant rich in bioactive isoflavones; however, the lack of a high-quality reference genome has limited elucidation of its isoflavone biosynthetic and modification network. Here, we present the first near telomere-to-telomere genome assembly of B. chinensis (4.18 Gb), generated using Illumina survey reads, PacBio HiFi and Oxford Nanopore long reads, and Hi-C scaffolding, achieving high completeness and accuracy (assembly BUSCO: 98.70%; LAI: 17.2). Ks/synteny-depth analyses and fossil-calibrated dating, with calibration at four fossil nodes, indicate two lineage-specific WGD events (~54.6 and ~27.3 MYA). These events drove significant expansions of key gene families involved in stress response and secondary metabolism. Leveraging this genome, we identified two key O-methyltransferases (BcOMT03 and BcOMT33), which are responsible for catalysing the biosynthesis of quality-marker compound irisflorentin. Meanwhile, BcUGT009, BcUGT119, BcUGT124, and BcUGT032 were characterised as glycosyltransferases with 7-O catalytic activity. Structural modelling and site-directed mutagenesis further elucidated the catalytic mechanism of BcUGT009, and its K404A mutant exhibited a significant increase in relative activity. Cross-species comparative analyses further revealed that convergent expansion of these key enzyme families underlies isoflavone biosynthetic capacity in both leguminous and non-leguminous plants. This study not only reveals the ancient polyploidization events of B. chinensis, the amplification of lineage-specific gene families and the biosynthetic pathway of characteristic isoflavones, but also provides a reference genome and functionally validated tailoring enzymes that will facilitate future heterologous pathway reconstruction and metabolic engineering of these isoflavones.

Indexed as

Evolution, MolecularGenome, PlantIridaceaeIsoflavonesTelomerePhylogenyIsoflavonesBelamcanda chinensisgenomeglycosylationisoflavones biosynthesismethylation

Identifiers

PMID41830405
PMCPMC13205724

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.